Peptide Blend Research Overview
Ultima-TB-500 (5mg) / BPC 157 (5mg) Blend is a dual peptide combination that merges two extensively studied compounds for tissue research applications. TB-500, derived from thymosin beta-4, is a 43-amino acid peptide that upregulates cell-building proteins such as actin and participates in cell migration, proliferation, and differentiation pathways in preclinical models. BPC-157, a pentadecapeptide containing 15 amino acids, derives from gastric juice protein and demonstrates effects on angiogenesis, nitric oxide pathways, and GABAergic system modulation in animal studies. This formulation from Ultima Pharmaceuticals provides researchers with equal concentrations of both peptides for comparative studies examining tissue repair mechanisms. The blend format enables scientists to investigate potential synergistic interactions between these two well-characterised compounds in controlled laboratory environments.
Laboratory Research Applications
This peptide combination serves multiple research purposes in tissue biology studies. TB-500 research focuses on wound healing mechanisms, cardiac tissue repair models, and inflammation modulation pathways in experimental settings. BPC-157 investigations examine tendon, ligament, bone, and gut tissue repair processes through extensive in-vivo animal studies. The dual formulation allows researchers at Stroid UK Shop to examine how these peptides may interact when studied together, potentially revealing novel mechanisms of action. Scientists investigating peptide combinations often utilise such blends to evaluate comparative efficacy and examine whether combined administration produces different outcomes than individual compound studies. Research applications extend to cellular regeneration studies, angiogenesis research, and tissue engineering investigations where both compounds’ documented properties may provide complementary mechanisms for examination.
Technical Specifications
| Parameter | Specification |
|---|---|
| TB-500 Content | 5mg per vial |
| BPC-157 Content | 5mg per vial |
| TB-500 Molecular Weight | 4963.44 g/mol |
| BPC-157 Molecular Weight | 1419.53 g/mol |
| TB-500 CAS Number | 77591-33-4 |
| BPC-157 CAS Number | 137525-51-0 |
| Storage Conditions | Lyophilised: -20°C, Reconstituted: 2-8°C |
| Manufacturer | Ultima Pharmaceuticals |
The blend maintains the individual properties of each peptide component while providing convenient dosing ratios for comparative research. Storage requirements follow standard peptide protocols with lyophilised powder requiring ultra-low temperature storage and reconstituted solutions requiring refrigeration with limited stability windows. Researchers studying selective modulators and peptide therapeutics often require precise technical specifications to ensure experimental validity and reproducible results across research protocols.
Research Compliance Statement
This Ultima-TB-500/BPC-157 blend is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must handle this peptide combination according to institutional biosafety protocols and applicable regulations governing research chemical use. All studies utilising this compound blend should be conducted by qualified personnel in appropriate laboratory facilities with proper documentation and oversight. This product is not approved by regulatory agencies for human or veterinary use and remains classified as a research chemical for scientific investigation purposes only.

